EQS-News: Dermapharm Holding SE

/ Key word(s): Annual Results/Annual Report

Successful financial year 2024: Dermapharm increases revenue and exceeds EBITDA guidance

28.03.2025 / 07:30 CET/CEST

The issuer is solely responsible for the content of this announcement.Read More

You might also be interested in reading Zoom updates terms after backlash, won’t train AI without consent.